Editas Medicine Inc
NASDAQ:EDIT
Editas Medicine Inc
Other Items
Editas Medicine Inc
Other Items Peer Comparison
Competitive Other Items Analysis
Latest Figures & CAGR of Competitors
Company | Other Items | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Editas Medicine Inc
NASDAQ:EDIT
|
Other Items
-$27m
|
CAGR 3-Years
47%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Other Items
-$1.2B
|
CAGR 3-Years
68%
|
CAGR 5-Years
-27%
|
CAGR 10-Years
N/A
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Other Items
-$1.7B
|
CAGR 3-Years
52%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Amgen Inc
NASDAQ:AMGN
|
Other Items
-$26.8B
|
CAGR 3-Years
-77%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-10%
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Other Items
-$2.9B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-93%
|
CAGR 10-Years
-101%
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Other Items
-$3.8B
|
CAGR 3-Years
-212%
|
CAGR 5-Years
-22%
|
CAGR 10-Years
-32%
|
See Also
What is Editas Medicine Inc's Other Items?
Other Items
-27m
USD
Based on the financial report for Mar 31, 2024, Editas Medicine Inc's Other Items amounts to -27m USD.
What is Editas Medicine Inc's Other Items growth rate?
Other Items CAGR 5Y
7%
The average annual Other Items growth rates for Editas Medicine Inc have been 47% over the past three years , 7% over the past five years .